150
Participants
Start Date
August 31, 2013
Primary Completion Date
November 30, 2014
Study Completion Date
November 30, 2014
Lurasidone 20 mg daily
Lurasidone 20 mg once daily
Lurasidone
Lurasidone 60 mg once daily
Placebo
Placebo
Richmond Behavioral Associates, Staten Island
Montefiore Medical Center PRIME, The Bronx
Finger Lakes Clinical Research, Rochester
Suburban Research Associates, Media
Neuroscience, Inc., Herndon
NeuroScientific Insights, Rockville
Kennedy Krieger Institute, Baltimore
University of Virginia, Charlottesville
Carilion Clinic, Roanake
Chapel Hill Neurology, Chapel Hill
Segal Institute for Clinical Research, Charleston
Institute for Behavioral Medicine, LLC, Smyrna
Sarkis Clinical Trials - Parent, Gainesville
Florida Clinical Research Center, LLC, Maitland
Medical Research Group of Central Florida, Sanford
Clinical Neuroscience Solutions, Inc., Orlando
Palm Springs Research Institute Inc, Hialeah
University of South Florida, St. Petersburg
Florida Clinical Research Center, LLC, Bradenton
Harmonex Neuroscience Research, Dothan
Clinical Neuroscience Solutions, Inc., Memphis
University of Kentucky, Lexington
The Ohio State University Nisonger Center, Columbus
University Hospitals Case Medical Center, Cleveland
Neurobehaviorial Medicine Group, PLLC, Bloomfield Hills
Capstone Clinical Research, Inc., Libertyville
Baber Research Group, Naperville
Lake Charles Clinical Trials, LLC, Lake Charles
Cutting Edge Research Group, Oklahoma City
Family Psychiatry of The Woodlands, P.A., The Woodlands
Ericksen Research & Development, LLC, Clinton
CRI Lifetree, Salt Lake City
Southwest Autism Research & Resource Center, Phoenix
Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas
Newport Beach Clinical Research Associates, Newport Beach
University of California San Francisco Medical Center, San Francisco
Cyn3rgy Research & Development, Gresham
Pacific Institute of Medical Sciences, Bothell
University of South Florida, Tampa
Jersey Shore University Medical Center, Neptune City
Childrens Specialized Hospital, Toms River
Sumitomo Pharma America, Inc.
INDUSTRY